Enzymatic vitreolysis with recombinant microplasminogen and tissue plasminogen activator

W Chen,X Huang,X-w Ma,W Mo,W-j Wang,H-y Song
DOI: https://doi.org/10.1038/sj.eye.6702931
IF: 4.4563
2007-01-01
Eye
Abstract:Purpose To generate microplasmin ( μ Plm) using recombinant microplasminogen ( μ Plg) and recombinant tissue plasminogen activator (rt-PA) before intravitreous injection and to investigate the efficacy of μ Plm in inducing posterior vitreous detachment (PVD). Methods Forty-eight female or male New Zealand white rabbits were randomized into three groups. Recombinant human μ Plg was incubated with rt-PA with a 200:1 molar ratio at 37°C for 40 min. The right eyes of groups 1, 2, and 3, were injected with 0.5, 1.0, and 1.5 U μ Plm in 0.1 ml respectively, and 0.1 ml balanced salt solution (BSS) was injected into the left eye as controls. Scanning electron microscopy (SEM), gross specimen examination, B-ultrasonography and optical coherence tomography (OCT) were performed to detect vitreoretinal interface. Results Over eighty percent of recombinant human μ Plg could be activated to active μ Plm by rt-PA after 40 min incubation. Complete PVD was found at vitreous posterior pole of μ Plm-treated eyes without morphological change of retina. Complete PVD of 25, 75, and 87.5% rabbit eyes was induced by 0.5, 1.0 and 1.5 U recombinant μ Plm respectively on day 1. The remnants of vitreous cortex at the posterior pole were dependent on the concentration of μ Plm. Among the four approaches for detecting PVD, SEM, gross specimen examination, and B-ultrasonography were more effective methods than OCT. Conclusion Intravitreous injection of 1.5 U μ Plm can effectively induce complete PVD in rabbit eyes on day 1 without morphological change of retina.
What problem does this paper attempt to address?